本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AN2 Therapeutics, Inc.

2.97
-0.0800-2.62%
盤後3.010.0400+1.35%18:27 EDT
成交量:57.35萬
成交額:173.67萬
市值:1.07億
市盈率:-2.55
高:3.34
開:3.00
低:2.90
收:3.05
52周最高:6.91
52周最低:1.00
股本:3,594.12萬
流通股本:1,075.52萬
量比:2.28
換手率:5.33%
股息:- -
股息率:- -
每股收益(TTM):-1.1641
每股收益(LYR):-1.1641
淨資產收益率:-52.14%
總資產收益率:-30.93%
市淨率:2.01
市盈率(LYR):-2.55

資料載入中...

2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/05

重要事件披露

Form 8-K - Current report
2024/08/28

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/19

重要事件披露

Form 8-K - Current report
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/03

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/25

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report